Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2015, Article ID 316739, 8 pages
http://dx.doi.org/10.1155/2015/316739
Research Article

Serum Survivin Levels and Outcome of Chemotherapy in Patients with Malignant Mesothelioma

1Pharmacogenetics Laboratory, Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, SI-1000 Ljubljana, Slovenia
2Institute of Oncology Ljubljana, SI-1000 Ljubljana, Slovenia
3Clinical Institute of Occupational Medicine, University Medical Center Ljubljana, SI-1000 Ljubljana, Slovenia

Received 9 July 2015; Revised 4 September 2015; Accepted 6 September 2015

Academic Editor: George Perry

Copyright © 2015 Katja Goričar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Katja Goričar, Viljem Kovač, Alenka Franko, Metoda Dodič-Fikfak, and Vita Dolžan, “Serum Survivin Levels and Outcome of Chemotherapy in Patients with Malignant Mesothelioma,” Disease Markers, vol. 2015, Article ID 316739, 8 pages, 2015. https://doi.org/10.1155/2015/316739.